Short
KTOV FDA Approval take gains and get out
As expected $NASDAQ:KTOV passed the FDA approval time to take some gains and move on to the next one.
finance.yahoo.com/news/fda-approves-kitov-consensi-treatment-174500954.html?.tsrc=rss
finance.yahoo.com/news/fda-approves-kitov-consensi-treatment-174500954.html?.tsrc=rss
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.